1IC
AMGN icon

1919 Investment Counsel’s Amgen AMGN Stock Holding History

1919 Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.29M Sell
23,399
-210
-0.9% -$27.4K 0.07% 229
2014
Q2 		$2.79M Sell
23,609
-1,180
-5% -$137K 0.06% 245
2014
Q1 		$3.06M Buy
24,789
+37
+0.1% +$4.49K 0.06% 233
2013
Q4 		$2.82M Buy
24,752
+70
+0.3% +$7.96K 0.06% 235
2013
Q3 		$2.76M Buy
24,682
+161
+0.7% +$17.5K 0.06% 234
2013
Q2 		$2.42M Buy
+24,521
New +$2.54M 0.06% 240

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

1919 Investment Counsel's AMGN Position: Q3 2014 in Review

1919 Investment Counsel reduced its Amgen (AMGN) stake by 0.89% in Q3 2014, selling an estimated $27.4K and leaving 23,399 shares worth $3.29M. The position accounts for 0.07% of the portfolio, ranked #229.

1919 Investment Counsel first reported a position in AMGN in Q2 2013 and has held it in 6 quarters since. 1,223 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • 1919 Investment Counsel held 23,399 shares of Amgen worth $3.29M as of Q3 2014.
  • 1919 Investment Counsel sold 210 Amgen shares in Q3 2014, an estimated $27.4K.
  • Amgen made up 0.07% of 1919 Investment Counsel's portfolio in Q3 2014, its #229 holding.
  • 1919 Investment Counsel first reported a position in Amgen in Q2 2013 and has held it in 6 quarters since.
  • 1,223 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.